| 1 |
32368395 | Inhibition of CDK2 reduces EZH2 phosphorylation and reactivates ERα expression in high-grade serous ovarian carcinoma. | 2020 |
1 |
| 2 |
33098638 | Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance. | 2020 Oct 24 |
3 |
| 3 |
29137354 | ERpS294 is a biomarker of ligand or mutational ERα activation and a breast cancer target for CDK2 inhibition. | 2017 Oct 13 |
1 |
| 4 |
22422660 | Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive breast cancer cells in a PPARγ independent manner. | 2012 Aug |
1 |
| 5 |
22564725 | Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells. | 2012 Jul |
2 |
| 6 |
20010939 | Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells. | 2010 Jan 19 |
1 |
| 7 |
20215421 | Estrogen receptor regulates E2F1 expression to mediate tamoxifen resistance. | 2010 Mar |
1 |
| 8 |
18838553 | Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT. | 2008 Oct 6 |
1 |
| 9 |
12096339 | Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest. | 2002 Jul 11 |
1 |
| 10 |
10096555 | Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells. | 1999 Mar 15 |
3 |
| 11 |
10428798 | Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex. | 1999 Aug 6 |
1 |
| 12 |
9199341 | Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. | 1997 Jul |
2 |